Skip to content
CCFR
  • Home
  • For Participants
    • Your Contribution
    • Research Discoveries
    • Protecting Your Privacy
    • FAQs
    • Site Newsletters
      • Cleveland Clinic – Cleveland
        Ohio, USA
      • Fred Hutch Cancer Center
      • Mayo Clinic – Phoenix, Arizona, USA
      • Ontario Familial Colorectal
        Cancer Registry
  • For Researchers
    • The CCFR Resource
    • Data Dictionaries
    • Questionnaires & Forms
    • Data Access
      • dbGaP
      • Collaborate
    • Publications Policy
  • News & Events
  • Publications
  • About Us
    • Who We Are
    • Our Team
    • Our Sites

Risks of Lynch syndrome cancers for MSH6 mutation carriers.

Authors Baglietto L, Lindor NM, Dowty JG, et al.
Citation J Natl Cancer Inst. 2010 Feb 3;102(3):193-201.
PubMedLink https://pubmed.ncbi.nlm.nih.gov/20028993/
PMCID PMC2815724

Posted in PublicationsTagged 2010
Read this next

Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I–III colon cancer: experience in 2 Canadian provinces.

© 2025 CCFR • Slightly Theme by Nick Ciliak.
Funded by the National Cancer
Institute (NCI), U01 CA167551, NIH USA
© 2023